- Rank, Name, Yield, Trend
- 1. Gilead: 7.37 Up
- 2. Teva: 4.19 Down
- 3. Genentech: 4.15 Up
- 4. Sanofi: 3.64 Flat
- 5. Abbott: 3.46 Flat
- 6. Pfizer: 3.37 Flat
- 7. Amgen: 3.31 Down
- 8. Wyeth: 3.25 Flat
- 9. Merck: 3.24 Down
- 10. Lilly: 3.20 Flat
- 11. BMS: 3.03 Down
- 12. Novo: 2.94 Up
- 13. AZ: 2.87 Down
- 14. Novartis: 2.74 Down
- 15. Schering: 2.69 Flat
- 16. J&J: 2.68 Down
- 17. GSK: 2.53 Down
- 18. Allergan: 2.44 Down
- 19. Shire: 2.26 Flat
- 20. Sepracor: 2.18 Up
- * Source: Companies’ quarterly earnings statements
20 Drug Companies Ranked by Sales and Marketing Efficiency
Subscribe to:
Post Comments (Atom)
1 comment:
The top 10 drugmakers by sales:
Source/Credits:The Associated Press (http://www.google.com/hostednews/ap/article/ALeqM5gPIn4z5KA7iVU7AxVVB5uXar26pgD96QO6DO0)
Largest drugmakers by 2008 pharmaceutical sales, according to estimates by data company IMS Health. The figures exclude medical devices, animal health products and some consumer health products.
Pfizer and No. 12 Wyeth's combined total would be about $59.1 billion and Merck and No. 18 Schering-Plough's $39.6 billion.
1. Pfizer, $43.3 billion
2. GlaxoSmithKline, $36.5 billion
3. Novartis, $36.2 billion
4. Sanofi-Aventis, $35.6 billion
5. Roche, $30.3 billion
6. Johnson & Johnson, $29.4 billion
7. Merck & Co. $26.2 billion
8. Abbott, $19.5 billion
9. Eli Lilly, $19.1 billion
10. Amgen, $15.8 billion
Post a Comment